Hans Van Bokhoven
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 165 publications
Astrocytes contribute to olanzapine-mediated reversal of Kleefstra Syndrome-associated neurodevelopmental regression.
Journal: The Journal of clinical investigation
Published: June 30, 2026
Generation of isogenic rescue iPSC lines by targeted CTG-repeat excision for myotonic dystrophy type 1.
Journal: Stem cell research
Published: April 29, 2026
Biallelic rescue of CTG18.1 in two Fuchs endothelial corneal dystrophy-derived iPSC lines (SCTCi047-A-2, SCTCi046-A-2) following a two-step gene editing strategy.
Journal: Stem cell research
Published: April 03, 2026
Generation of iPSC lines from myotonic dystrophy type 1 patients with varying CTG repeat lengths.
Journal: Stem cell research
Published: March 25, 2026
Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives.
Journal: Nature reviews. Neurology
Published: September 01, 2025
Pathological mechanism in Fuchs endothelial corneal dystrophy and myotonic dystrophy type 1: more than meets the eye.
Journal: Progress in retinal and eye research
Published: July 11, 2025
Human neuronal networks on micro-electrode arrays as a tool to assess genotype-phenotype correlation in CACNA1A-related disorders.
Journal: Stem cell reports
Published: June 17, 2025
Genetic Inactivation of the Serotonin Transporter Dysregulates Expression of Neurotransmission Genes and Genome-Wide DNA Methylation Levels in the Medial Prefrontal Cortex of Male Rats During Postnatal Development.
Journal: Developmental neurobiology
Published: March 22, 2025
Comprehensive genotypic, phenotypic, and biochemical characterization of GOT2 deficiency: A progressive neurodevelopmental disorder with epilepsy and abnormal movements.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: January 13, 2025
Biallelic excision of the CTG18.1 expansion in two Fuchs endothelial corneal dystrophy-derived iPSC lines and one control (SCTCi046-A-1, SCTCi047-A-1 and SCTCi041-A-1) using an episomal vector-based CRISPR/Cas9 approach.
Journal: Stem cell research
Published: December 10, 2024
Last Updated: 09/26/2026